Product Overview
Tesamorelin is a 44-amino-acid growth hormone-releasing hormone (GHRH) analog supplied by PeptaCo for qualified laboratory research. It is identical to native human GHRH and represents the full-length peptide sequence. Tesamorelin is widely referenced in endocrinology research and GH release mechanism investigations.
Key Product Details
- Product Name: Tesamorelin
- Specification: As listed per catalog variant
- Product Form: Lyophilized powder
- Category: GH Secretagogue Research Peptides
- Peptide Length: 44 amino acids
Chemical Identity
Tesamorelin is identical to the full 44-amino-acid sequence of native human GHRH. Molecular Weight: ~5136 Da. The full-length sequence provides complete receptor engagement for research into physiological GH release patterns. This listing covers Tesamorelin in multiple specifications (5mg, 10mg).
Research Context
Tesamorelin is extensively referenced in endocrinology research for studying physiological GH release, GHRH receptor pharmacology, and pituitary function. As a full-length GHRH analog, it serves as a reference standard in comparative studies with shorter GHRH fragments. PeptaCo supplies Tesamorelin in multiple specifications to support diverse research requirements.
Storage and Handling
Store in a cool, dry place away from direct light. Follow batch-specific storage instructions provided with the certificate of analysis. Avoid repeated freeze-thaw cycles. Handle using standard laboratory practices.
Documentation and Quality
Batch-specific analytical documentation is available to qualified customers upon request. Contact PeptaCo with the product SKU and required quantity to request the current documentation package, which may include identity confirmation, purity analysis, and batch traceability records.
Important Notice
This product is supplied for qualified laboratory research and analytical applications only. It is not for human or veterinary use. Product specifications may vary by batch. Appearance, analytical results, counter-ion information, and other release specifications should be confirmed against the certificate issued for the current batch.
